Demand of Life Cycle Management Industry : Technology, Applications, Growth and Status 2017

ResearchMoz presents professional and in-depth study of "Life Cycle Management Strategies - Optimizing revenues and defending generic competition".

GBI Research’s latest report, ""Life Cycle Management Strategies Optimizing revenues and defending generic competition"" discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies, and keys to successful implementation of the strategies. The report provides detailed case studies for each of the key strategies such as indication expansion, reformulation, fixed-dose combinations, pricing strategies and so on.

Companies mentioned in the report are AbbVie, Actavis, AstraZeneca, Cipla, Gilead, GlaxoSmithKline, Gleevec, Janssen, MannKind, Merck, Novartis, Orexo, Otsuka, Pfizer, Roche, Salix Pharmaceuticals, Sanofi-Aventis, Solvay, Teva and Vifor Pharma.

Scope

    Introduction of LCM and product life cycle
    Objectives of LCM and factors impacting the choice of strategies
    LCM strategies depending on the way of approach
    Impact of LCM strategies on sales and growth trend of selected products
    Patent term extension and market exclusivity in the US and Europe
    LCM strategies of pipeline drugs of key players
    Keys to successful implementation of LCM strategies

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=322850

Reasons to buy

    Identify the key LCM strategies used by most of the pharmaceutical companies
    Analyze the strategies to increase lifecycle and revenues of a drug
    Gain an understanding on the implementation of multiple strategies for a single product by including case studies
    Understand the operational pipeline strategies of key players

Executive Summary

Introduction
Overview of Product Life Cycle
Product Life Cycle Curve
Objectives of Life Cycle Management (LCM)
Classification and Benefits of LCM Strategies
Strategic Planning for LCM
Factors Impacting Choice of LCM Strategies
Developmental Strategies

Make an Enquiry about TOC @ http://www.researchmoz.us/enquiry.php?type=E&repid=322850

Indication Expansion/Sequencing and Repositioning
Patient Subpopulations and Personalized Medicine
Reformulation
New Dosage Forms
New Route of Administration
Special Cases
New Dosage Strengths and Regimen
Fixed-Dose Combination and Co-packaging
Next Generation Products and Modified Chemistry
Metabolites
Chiral Switching
Polymorphs
Multiple Developmental Strategy Approach
Commercial Strategies
Rx-to-OTC/BTC Switch
Geographical Expansion
Pricing Strategy and Tactics
Pricing Strategy for Targeting Multiple Indications
Coupons
Co-pay Cards
Awareness, Brand Loyalty and Service Programs
Regulatory and Legal Strategies
Authorized Generics
Legal Defense and Pay for Delay
Citizen’s Petition
Patent Term Extension and Market Exclusivity
The Pharmaceutical Pipeline and LCM
Successful Implementation of LCM Strategies

Browse Report @ http://www.researchmoz.us/life-cycle-management-strategies-optimizing-revenues-and-defending-generic-competition-report.html

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/